Psilocybin AUD Trial Found Exploratory TLE4 and RASGRP4 Methylation Signals

Psilocybin AUD Trial Found Exploratory TLE4 and RASGRP4 Methylation Signals

TL;DR: A 2026 exploratory study in Translational Psychiatry found blood DNA methylation changes after 25 mg psilocybin in detoxified alcohol use disorder patients, including findings near TLE4 and RASGRP4, but the small trial did not establish a definitive AUD biomarker. Key Findings 37 AUD patients: The methylation analysis used a randomized, double-blind psilocybin trial completed …

Read more

fMRI Noise Signal Tracked Nicotine Craving and Stimulant Effects

fMRI Noise Signal Tracked Nicotine Craving and Stimulant Effects

TL;DR: A 2026 study in Biological Psychiatry: Global Open Science found that systemic low-frequency oscillation (sLFO), a slow whole-body physiology readout usually treated as functional MRI noise, tracked nicotine dependence, cue-induced craving, abstinence, and stimulant-related task performance across four fMRI cohorts. Key Findings The study analyzed four fMRI cohorts: Researchers examined a 64-person cigarette cue-reactivity …

Read more

Youth Cannabis Use Linked to Flatter Cognitive Development

Youth Cannabis Use Linked to Flatter Cognitive Development

TL;DR: A 2026 Neuropsychopharmacology study of 11,036 ABCD participants found youth who initiated cannabis use showed flatter cognitive-development trajectories from ages 9 to 17, with hair-detected THC linked to worse episodic-memory change. Key Findings 11,036 youth were followed: Researchers used the Adolescent Brain Cognitive Development (ABCD) Study to track neurocognitive performance from late childhood into …

Read more

Opioid Use Disorder Drove 30-Year Rise in US Substance Use Burden

Opioid Use Disorder Drove 30-Year Rise in US Substance Use Burden

TL;DR: A 2026 study in Population Health Metrics used Global Burden of Disease 2019 estimates and found that U.S. substance-use-disorder health loss rose sharply from 1990 to 2019, with opioid use disorders driving the largest increase. Key Findings 19.5 million cases: Estimated U.S. substance use disorder prevalence increased from 12.6 million in 1990 to 19.5 …

Read more

Semaglutide Reduced Heavy Alcohol Drinking by 13.7 Percentage Points vs Placebo in 26-Week Trial of Adults With AUD and Obesity

Semaglutide Reduced Heavy Alcohol Drinking by 13.7 Percentage Points vs Placebo in 26-Week Trial of Adults With AUD and Obesity

TL;DR: A 2026 randomized double-blind placebo-controlled trial in The Lancet (N=108 adults with both moderate-to-severe alcohol use disorder and obesity) found that 26 weeks of once-weekly 2.4 mg semaglutide reduced heavy drinking days by 41.1 percentage points compared with a 26.4-point reduction on placebo — a 13.7-point treatment difference, with parallel drops in alcohol craving, …

Read more

Prior Cocaine Use Disrupted Orbitofrontal Hidden-State Coding in Rats

Prior Cocaine Use Disrupted Orbitofrontal Hidden-State Coding in Rats

TL;DR: A 2026 study in eLife found that prior cocaine self-administration disrupted how rat orbitofrontal cortex (OFC), a frontal brain region involved in task structure and flexible behavior, encoded hidden states in an odor-sequence task. Key Findings 3,881 single units: The study recorded 3,881 lateral OFC single units while rats performed a sequential odor task. …

Read more

New Psychoactive Stimulants and Hallucinogens Found in 70 Fatal Poisonings

New Psychoactive Stimulants and Hallucinogens Found in 70 Fatal Poisonings

TL;DR: A 2026 study in Drug and Alcohol Dependence Reports found 70 known Australian fatal poisonings involving new psychoactive stimulants and hallucinogens (NPSH), a category of newer stimulant- or hallucinogen-like drugs that often appeared alongside other psychoactive substances. Key Findings Researchers identified 70 fatal drug-toxicity cases in Australia from 2000 to 2025 where NPSH were …

Read more

Addiction Brain Differences Followed Network and Receptor Architecture

Addiction Brain Differences Followed Network and Receptor Architecture

TL;DR: A 2026 medRxiv preprint from the ENIGMA Addiction Working Group used structural MRI from 2,782 people with substance use disorder (SUD) and 1,951 controls and reported that addiction-related brain differences followed cortical network hubs and neurotransmitter receptor maps. Key Findings 4,733-person MRI sample: Researchers compared 2,782 people with SUD against 1,951 controls across 51 …

Read more

Semaglutide Reduced Cocaine-vs-Food Choice in Rats

Semaglutide Reduced Cocaine-vs-Food Choice in Rats

TL;DR: A 2026 rat study in Neuropsychopharmacology reported that repeated semaglutide treatment reduced cocaine-vs-food choice in male and female rats, supporting further clinical testing for cocaine use disorder rather than proving human benefit. Key Findings 5-day treatment: Rats received repeated semaglutide treatment across 5 days rather than a single acute dose. Two active doses: Both …

Read more

Early Regular Adult-Content Viewing Linked to Higher Distress Profile

Early Regular Adult-Content Viewing Linked to Higher Distress Profile

TL;DR: A 2026 study in Computers in Human Behavior grouped 1,316 U.S. adults by when they first saw sexually explicit media and when regular viewing began; the highest distress appeared in people who moved into regular viewing early, while late regular engagement looked lower-risk in this cross-sectional survey. Key Findings Three trajectories emerged: researchers identified …

Read more